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Summary
Prostacyclin (PGIJ appears to be synthesized in the
lungs of man and experimental animals. It has been
stated that PGI2 must be regarded as a local hormone
that inhibits platelet adhesion to vessel walls only very
close to the site of synthesis.
The wide range 'of normal values given for PGI2 may
be related to the sensitivity and exclusiveness of the
different assay techniques used.
In animals hyperventilation increases PGI2 synthesis
by the lung, but in agreement with other authors we
demonstrated that hyperventilation did not influence
PGI2 synthesis in man. We used a radio-immunoassay
technique to'estimate PGl2 levels.
SAfrMedJ1984;6S: 135-136.
Prostacyclin (PGI2) is continuously generated from arachidonic
acid and prostaglandin endoperoxides, mainly in the vascular
endothelium of the lungs. I Unlike other prostaglandins it is not
metabolized in its passage through the lung.2 Because this
prostaglandin is the most potent anti-aggregator in the body it
appears to offer a homeostatic mechanism for the control of
platelet aggregation in vivo. 3,4 Edlund er al., 5 quoting Steer er al. 6
and Sonnenfeld and Wennmalm,7 stated that the lowest blood
level required for this function is 30-90 pg/m!. If they are
correct, one would expect blood levels ofthis range to be present
under normal conditions.
There is controversy about normal PG12 blood levels in man,
as well as about how the mode of ventilation influences these
values. In 12 patients being prepared for total hip replacement
under general anaesthesia, we measured PGI2 and blood gases
before anaesthesia and again after 50 ± 4 (mean ± SE) minutes of
stable anaesthesia (prior to the onset of surgery). The arterial
carbon dioxide tension (paco2) was markedly lower during
anaesthesia than in the awake state (P < 0,001). Our aim was to
determine the effect of Paco2 change on PG12 synthesis and to
compare our results with those in the current literature.
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Patients and methods
Patients
Twelve patients, 6 males and 6 females with a mean age of 69
years (range 55 - 82), were scheduled for Charnley total hip
replacements. No anti-prostaglandin medication was allowed
during the week preceding the operation.
Premedication consisted of pethidine and promethazine in
doses appropriate to the patients' physical status. Under local
anaesthesia an intravenous line was established, a central venous
pressure line was inserted via a basilic vein and a 20 G A catheter
inserted into a radial artery.
The patients breathed oxygen for 4 minutes and were then
anaesthetized with thiopentone (± 2 mg/kg) followed by
alcuronium (0,25 mg/kg) or pancuronium (0,1 mglkg). They
were ventilated with a fractional inspiratory oxygen concentration
(Fio2) of 0,4. The trachea was sprayed with xyloc.aine 4% and a
No. 8 cuffed endotracheal tube was inserted. Anaesthesia was
maintained with a nitrous oxide and oxygen mixture, the Fio2
being 0,4. Ethrane « 1%) and fentanyl (0,2-0,3 mg) in divided
doses were added. Ventilation was performed with a Bird Mk II
and Ventviva, maintaining the end-expiratory CO2 at ± 4,5
vols %. Curarization was reversed with neostigmine and atropine.
Monitors
Arterial pressure was continuously monitored by an AE 840
pressure transducer and a Simonsen and Weel oscilloscope with
digital display. Central venous pressure was monitored with a
water manometer. Expiratory CO2 was monitored using a
Godart infant capnograph. Paco2 and pH were checked with a
Gas Check AVL apparatus at the same times that PGI2 values
were determined. ECG, oesophageal temperature and Fio2 were
also monitored continuously.
During the trial period all parameters were at accepted normal
values.
Sampling
Stock solutions were prepared as follows: EDTA 10 gldl and
theophylline 540 mgldl were dissolved in distilled water and pH
was adjusted to 7,0; 120 mg aspirin was added to 1 m! methyl
alcohol.
On the day ofoperation 40 /-Ll aspirin solution was added to 200
/-Ll theophylline-EDTA solution in polypropylene collecting
tubes. A 5 m! blood sample was collected in the tube and mixed.
The tube was put into crushed ice and immediately transported
to the laboratory, where it was centrifuged at4°C and 1 500g for
10 minutes. The top of the serum layer was removed. The latter
procedure was repeated and the serum stored in capped
polypropylene tubes at -20°C until assayed.
The New England Nuclear 6-keto-prostaglandin F1a (3H)
RIA Kit was used for the radioimmunoassay (RIA) of 6-keto-
PGI1a. Assays were carried out direcdy on the stored plasma
without prior extraction or chromatography.
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Radial arterial blood samples were taken in the prescribed
tubes before onset of anaesthesia and again before the onset of
surgery. Blood gases were measured simultaneously.
Results
The results ofPG12and Paco2estimations are presented in Table
1. The mean Paeo2 was 5,9 ± 0,2 kPa before anaesthesia and 4,7
± 0,1 kPa during anaesthesia. A paired Student's r test
demonstrated a significant difference (P < 0,001).
TABLE I. Paco, AND PGI2 LEVELS IN PATIENTS BEFORE
ANAESTHESIA AND 50 ± 4 (MEAN ± SE) MINUTES AFTER
STABLE ANAESTHESIA HAD COMMENCED
Before anaesthesia During anaesthesia
Patient Paco2 PGI2 Paco2 PGI2
No. (kPa) (pg/ml) (kPa) (pg/ml)
1 5,1 32 3,7 190
2 5,2 190 5,1 290
3 5,6 135 4,7 135
4 7,4 50 4,8 50
5 6,8 330 5,1 280
6 5,6 50 5,3 50
7 6,4 23 4,8 30
8 5,6 286 4,7 320
9 4,9 135 4,4 280
10 6,5 251 4,7 234
11 5,7 229 4,9 206
12 5,9 240 5,1 106
Mean ± SE 5,9 ± 0,2 163 ± 34 4,7 ± 0,1 183 ± 31
The mean PGI2 value was 163 ± 34 pg/ml before anaesthesia
and 183 ± 31 pg/ml during anaesthesia. These values were not
significantly different (paired Student's r test).
Discussion
In anaesthetized cats and rabbits it has been demonstrated 1.8 that
PGI2 is continuously generated by the lungs. The systemic
arterial level is always higher than the venous level, which
substantiates this finding. s Gryglewski er al. l have demonstrated
that vigorous hyperventilation of anaesthetized cats increases
PG12release from the lungs. In isolated rat lungs Korbut er al. 9
demonstrated that doubling the ventilation resulted in an
increase of two and a half times the normal release of PG12,
There is evidence that in animals the lung synthesizes PG12 and
that hyperventilation increases this release. I
In patients undergoing cardiac catheterization Hensby er al. 10
observed higher levels (207 ± 33 pg/ml) in systemic arterial than
in pulmonary arterial blood (131 ± 13 pg/ml) indicating PGI2
synthesis in the lung. This was confirmed by Edlund er al., 5who
found no PG12 in venous blood and low levels in arterial blood
« 50 pg/ml).
There is a wide range of 'normal' arterial blood values for PG12
in awake patients, from < 50 to 207 pg/m!. 5,10 In our 12 patients
the range was 23-330 pg/ml, which compares favourably with
the results mentioned above. PGI2values have been assayed by
RIA5 or gas chromatograph-mass spectrometer lO techniques.
Blair er al." stated that until assay techniques are standardized
and become more specific, PGI2 results will vary widely.
In animals hyperventilation increases PGI2 synthesis' but in
man the evidence is not conclusive. Christ-Hazelhof and
ugreren 12 hyperventilated awake patients with a CO2-rich
oxygen mixture to the extent of 75 l/min for 5 minutes. They
then measured PGI2, as PGIIO!, in pulmonary artery and vein
samples, but could not detect any PGI2. They concluded that
PG12 does not fulfil a role in the vascular system at any distance
from the site of synthesis. The healthy human body functions
under conditions of optimal utilization of its resources and one
would doubt the oversight of such a potent inhibitor of platelet,
aggregation.
In 4 patients Edlund er al. 5found awake PG12levels of 17 ± 4
pg/m!. These patients were then anaesthetized and ventilated
with a minute volume of about 8 litres and 'optimized Peo2'.
After 15 minutes ofanaesthesia mean arterial PG12levels rose to
191 ± 21 pg/mI (a tenfold increase on pre-anaesthetic kvels).
Unfortunately we do not have Paeo21evels available to judge the
degree of ventilation. In our patients arterial Paeo2 'levels
measured simultaneously with those of PG12 were significantly
lower (P < 0,001) when these patients were anaesthetized than
when they were awake (Table I); PGI2 1evels ranged from 30 to
320 pg/ml (mean 183 ± 31 pg/ml), and values were almost
identical whether the patient was awake or anaesthetized. In
view of our patients' mean age (69 ± 2 years), it was not deemed
advisable to lower the Paco2 further. Our results obtained with
moderate hyperventilation and those of Christ-Hazelhof and
Nugreren l2 with extreme hyperventilation suggest that hyper-
ventilation does not influence PG12 synthesis in man.
In animals, however, there is a definite increase in PG12
synthesis with hyperventilation. Gryglewski er al. I stated:
'Lungs can certainly regulate their production ofPG12 , We have
seen in 3 experiments that an artificial vigorous hyperventilation
(80 breaths/minute) in anaesthetized cats is followed by an
increased release from lungs ofa disaggregating principle ... .' It
would appear that the difference in man and animal may be
related to the vigorous ventilation animals were subjected to, or
due to species variation.
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